Food News and Research

RSS

Researchers find compound that reverses type 1 myotonic dystrophy

A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.

7 Nov 2009

Illegal flavored cigarettes: FDA issues warning letters to companies selling them

The U.S. Food and Drug Administration is enforcing the flavored cigarette ban provision of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) by issuing several warning letters to companies continuing to sell illegal flavored cigarettes to consumers in the United States through their Web sites.

7 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Boston Scientific reaches agreement with DOJ related to product advisories issued by its Guidant subsidiary

Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.

6 Nov 2009

BioSpecifics Technologies revenues increases by 100% for the third quarter ended September 30, 2009

BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009.

6 Nov 2009

People pay more for products that carry detailed nutritional information than for light items

People would be willing to pay more for products that carry detailed nutritional information than for the so-called light items. Thus it has been confirmed by researchers from the University of Santiago de Compostela (USC) and the Centre for Agro-Food Research and Technology of Aragón (CITA) in a new study on the nutritional labelling of breakfast biscuits.

6 Nov 2009

Citracal Calcium plus Heart Health helps support bone and heart health in women

Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.

6 Nov 2009

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

School-based physical education plays a key role in curbing obesity and improving fitness among adolescents from low-income communities, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley.

6 Nov 2009

Patent covering the approved administration of Kuvan with food issued

BioMarin Pharmaceutical Inc. announced today that the United States Patent and Trademark Office has issued a patent covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food for the treatment of phenylketonuria (PKU). The patent expires in 2024.

6 Nov 2009

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Varian, Inc. announced today the release of the 325-MS triple-quadrupole LC/MS (liquid chromatograph/mass spectrometer) for the efficient detection and identification of chemical compounds in high-throughput laboratories performing environmental, food safety, and toxicology analyses.

6 Nov 2009

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.

6 Nov 2009

Climate change is the biggest health threat to children in the 21st century, says new report

Climate change is the biggest health threat to children in the 21st century and represents an immediate global emergency, according to a new report, "Feeling the Heat," released today by Save the Children, at the Barcelona United Nations Climate Change talks.

6 Nov 2009

ImmunoLin provides immediate benefit to the function of immune system and gut

A new study provides evidence that ImmunoLin®, an all natural and GRAS approved source of immunoglobulin, will provide immediate benefit to the function of the immune system and the gut. Immunoglobulins, or antibodies, are specialized proteins found in blood that the immune system naturally produces for immunity.

6 Nov 2009

USPTO issues Notice of Allowance to NovaDel Pharma

NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.

6 Nov 2009

Tobacco companies attempt to block key provisions of new tobacco regulation law, federal judge rejects motion

In a clear victory for public health, a federal judge in Kentucky today rejected a motion by tobacco companies to block key provisions of the new law giving the U.S. Food and Drug Administration (FDA) the power to regulate tobacco products. Specifically, today's decision strongly supports the government's authority to prevent the industry from making health claims about its products without FDA approval.

6 Nov 2009

Prevalence of lactose intolerance may be far lower than previously estimated, says study

Prevalence of lactose intolerance may be far lower than previously estimated, according to a study in the latest issue of Nutrition Today. The study, which uses data from a national sample of three ethnic groups, reveals that the overall prevalence rate of self-reported lactose intolerance is 12 percent - with 7.72 percent of European Americans, 10.05 percent of Hispanic Americans and 19.5 percent of African Americans who consider themselves lactose intolerant.

6 Nov 2009

Food News and Research

Researchers find compound that reverses type 1 myotonic dystrophy

Illegal flavored cigarettes: FDA issues warning letters to companies selling them

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Boston Scientific reaches agreement with DOJ related to product advisories issued by its Guidant subsidiary

BioSpecifics Technologies revenues increases by 100% for the third quarter ended September 30, 2009

People pay more for products that carry detailed nutritional information than for light items

Citracal Calcium plus Heart Health helps support bone and heart health in women

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

Patent covering the approved administration of Kuvan with food issued

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Climate change is the biggest health threat to children in the 21st century, says new report

ImmunoLin provides immediate benefit to the function of immune system and gut

USPTO issues Notice of Allowance to NovaDel Pharma

Tobacco companies attempt to block key provisions of new tobacco regulation law, federal judge rejects motion

Prevalence of lactose intolerance may be far lower than previously estimated, says study

FDA: Sexual enhancement product "Stiff Nights" can dangerously lower blood pressure and is illegal

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

School Grants program promotes better food choices and healthier lifestyles for school kids

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News